MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)
Phase 2
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Registration Number
- NCT00371007
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Brief Summary
A clinical study to determine the safety and efficacy of MK-0431 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 126
Inclusion Criteria
- Patients have type 2 diabetes mellitus
- On diet/exercise therapy
Exclusion Criteria
- Patients have type 1 diabetes mellitus
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method HbA1c, safety and tolerability
- Secondary Outcome Measures
Name Time Method Plasma glucose